Press Releases

OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ:OSIS) today announced that its Optoelectronics and Manufacturing division has received an order valued at approximately $12 million to supply electronic sub-assemblies to a leading OEM in the secure communications industry. OSI Systems' President and Chief Executive Officer, Ajay Mehra, commented, "We're pleased to expand this relationship with our customer. Our focus remains on delivering high-quality electronic sub-assemblies at scale, supported by strong execution and a flexible global manufacturing footprint." About OSI Systems OSI Systems designs and manufactures specialized electronic systems and components for critical

Firefighter-led wildfire mitigation company cites crew safety, environmental stewardship, and operational considerations as key factors in selection CitroTech (NYSE:CITR), a specialty chemical company developing environmentally safe fire inhibitor solutions, and All Risk Shield, a firefighter and veteran-owned wildfire mitigation and structure hardening services provider, today announced a strategic partnership under which All Risk Shield has selected CitroTech as its preferred fire inhibitor to treat residential, commercial, and estate properties across California. The decision follows independent testing by All Risk Shield to evaluate the leading fire retardant products used in wildfi

- Three-year, ~$3M commitment to expand leadership development, strengthen HIV education and engagement, and preserve the HIV movement's history for future generations - The National AIDS Memorial together with the Gilead Foundation today announced a transformative three-year, ~$3 million commitment to help preserve the history of the HIV epidemic, expand public education and engagement, and inspire the next generation of leaders advancing access to care. The fight against HIV/AIDS has always depended on more than medicine. It has required scientific innovation, public education, activism, compassion, communities caring for one another through crisis and change, and a shared commitment to

Macy's, Inc. (NYSE:M) today announced that Tom Edwards, chief operating officer and chief financial officer, will participate in the Jefferies Consumer Conference on Tuesday, June 16, 2026. About Macy's, Inc. Macy's, Inc. (NYSE:M) is a trusted source for quality brands through our iconic nameplates – Macy's, Bloomingdale's and Bluemercury. Headquartered in New York City, our comprehensive digital and nationwide footprint empowers us to deliver a seamless shopping experience for our customers. For more information, visit macysinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260611717589/en/ Media – Isabella Hershey communications@macys.com Inv

Strategic Combination Designed to Accelerate Deployment of Power-Ready AI Data Centers Amid Industry-Wide Delays Nixxy, Inc. (NASDAQ:NIXX) today highlighted the growing opportunity created by the accelerating shortage of AI-ready data center infrastructure across North America and outlined how its recently announced strategic combination with Tachyon9 Corporation is designed to address one of the industry's most significant bottlenecks. Recent industry reports indicate that nearly half of all U.S. AI data center projects planned for deployment in 2026 have been delayed or canceled due to power constraints, equipment shortages, permitting challenges, and construction delays. Industry ana

MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that the company will present four posters at the PHA 2026 International PH Conference and Scientific Sessions taking place June 11-14 in Dallas. Liquidia will present data from Cohort A of its ASCENT study of YUTREPIA® (treprostinil) inhalation powder, including patient-reported cough outcomes in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) over 24 weeks of treatment. The company will also present

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which received U.S. Food and Drug Administration clearance in 2024 for predicting the one-year risk of atrial fibrillation or flutter (AF). The study, titled "Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter," was recently published in Heart Rhythm. AF is the most prevalent cardiac arrhythmia and is associated with an increased risk of stroke, heart failure and death. Because AF is frequently asymptomatic and paroxysmal, it

CNH accelerates product development and parts delivery with €21M investment in advanced simulation and automated logistics CNH invests €21M in advanced simulation and automated logistics in Modena, Italy, to accelerate product development and parts delivery across EuropeNew virtual simulation ecosystem reduces development time by over 30% by identifying design issues earlier and optimizing testing processesAutomated AutoStoreTM warehouse enables 24-hour parts availability for 1,200+ dealers, improving speed, efficiency, and sustainability Modena, June 11, 2026 CNH (NYSE:CNH), a global leader in agricultural and construction equipment and technology, has inaugurated an advanced virtual sim

Interim CMO Anna Sayre to resume previous role as SVP, Global Brand Marketing The Trade Desk, a leading global advertising technology company, today announced the appointment of Sarah Gavin as Chief Marketing Officer and Executive Vice President. Gavin will lead The Trade Desk's marketing organization, overseeing global brand, communications, customer marketing, and demand generation efforts. She will play a key role in elevating the company's market presence, deepening engagement with customers and partners, and advancing its vision for the open internet. Gavin joins the company on June 15, based in their Bellevue office, and will report directly to CEO and Founder Jeff Green. Most rec

Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), today announced the grant by the European Patent Office (EPO) of European Patent No. EP4252651, titled "Electrocardiogram-Based Assessment of Diastolic Function." The patent covers machine-learning models and methods for computing quantitative estimates of echocardiogram parameters indicative of diastolic function using ECG data and patient demographic parameters. "Securing European patent protectio

FREDERICK, Md., June 11, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ:TOMZ), a global leader in disinfection and decontamination solutions, today announced an update on its expanding global outreach, a significant increase in inbound market demand, and its strategic role in public health readiness ahead of historic international events. TOMI's premier SteraMist iHP technology supports an elite, diverse customer base that includes healthcare coalitions, hospital networks, special pathogen units, and specialized medical transportation companies. SteraMist remains a critical component in worldwide outbreak mitigation, trusted by global health organizations to

LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including mild-to-severe obstructive sleep apnea ("OSA"), today announced that it intends to file a registration statement with the U.S. Securities and Exchange Commission (the "SEC") for a proposed rights offering pursuant to which the Company would distribute, as a dividend, transferable subscription rights to its shareholders. The Company currently expects to file a registration statement in connection with th

MOUNTAIN VIEW, Calif., June 11, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced the publication of a peer-reviewed case study from researchers at Moffitt Cancer Center was recently published in Radiology Case Reports. The case study highlights potential optimization of the TAMP procedure with RenovoCath to deliver intra-arterial gemcitabine (a commonly used chemotherapy) directly near a tumor (rather than traditional systemic IV administration) in a patient with locally advanced pancre

- Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining seven patients in the trial -  - Marks the latest in a series of regulatory successes in this indication, following FDA's recognition of Alpha DaRT's potential through its Breakthrough Device Designation for recurrent glioblastoma (GBM) and Alpha Tau's selection for the FDA's prestigious Total Product Life Cycle (TPLC) Advisory Program (TAP) - - With approximately 14,000 Americans newly diagnosed with glioblastoma each year and median survival after recurrence typically measured in months, Alpha D

Acquisition Adds Ultra-Low Cost, Mass Producible Fixed-Wing Drone Capabilities into Draganfly's Defense Portfolio Tampa, FL., June 11, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) ("Draganfly" or the "Company") is pleased to announce that it has completed its previously announced acquisition of Skip Dynamix Corporation ("Skip Dynamix"), as described in the Company's press release dated May 18, 2026 (the "Transaction"). The aggregate purchase price for the Transaction was up to US$7,525,000, consisting of: a cash payment of US$2,525,000 paid at closing;US$2,500,000 in Draganfly common shares ("Draganfly Shares") at a deemed price of US$6.46 per share, issuab

IRVING, Texas, June 11, 2026 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (NASDAQ:EBON, the "Company, " "we, " "us" or "our")) today announced that its subsidiary had successfully won a bid for certain industrial land in Xinghe County, Ulaanqab City, Inner Mongolia Autonomous Region, China. The Company plans to construct production facilities for high-efficiency amorphous and nanocrystalline new materials on the site. This project will advance the Company's expansion across renewable energy, new materials, and the green power industry chain, accelerating its strategic upgrade towards becoming a global provider of energy-related new material solutions. Leveraging Inner Mongolia's

Comcast Corporation will host a conference call with the financial community to discuss financial results for the second quarter on Thursday, July 23, 2026, at 8:30 a.m. Eastern Time (ET). Comcast will issue a press release reporting its results earlier that morning. The conference call will be broadcast live on Comcast's Investor Relations website at www.cmcsa.com. A replay of the call will be available starting at 11:30 a.m. ET on Thursday, July 23, 2026, on the Investor Relations website. To automatically receive Comcast financial news by email, please visit our Investor Relations website and subscribe to Email Alerts. About Comcast Corporation Comcast Corporation (NASDAQ:CMCSA)

MELBOURNE, Australia, June 11, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced it has approved a share repurchase program authorizing the Company to repurchase up to $5.0 million of its common stock. "With our recent advancements of the Company's lead asset, PRP, towards entering the clinic with a novel, first-in-class cancer therapy to treat and prevent metastatic cancer from solid tumors with a pivotal Phase 1b, First-In-Human study in 30 to 40 advanced cancer patients, the management team believe

CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of John Fortson as Executive Vice President (EVP) and Chief Financial Officer (CFO), effective July 20. Mr. Fortson joins Dentsply Sirona with more than 25 years of leadership experience in finance, operations, and strategy across both public and private equity-backed companies. He has served for 13 years as either CFO or Chief Executive Officer of global manufacturing and industrial businesses. Throughout his career, he has executed large-sc

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE:SAR) ("Saratoga Investment" or "the Company"), a business development company, today announced that its Board of Directors has declared a base quarterly dividend of $0.75 per share in aggregate for the second quarter of fiscal 2027, paid in three monthly dividends as follows: MonthAmount per ShareRecord DatePayment DateJune 2026$0.25July 6, 2026July 23, 2026July 2026$0.25August 5, 2026August 25, 2026August 2026$0.25September 3, 2026September 23, 2026     "Our board of directors approved an unchanged quarterly dividend of $0.75 per share for the second quarter of fiscal 2027, paid in monthly increments of $0.25 per